Skip to content

Clinical trials

Lung Diseases trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Unknown status Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20163
20171
20181
20192
20201
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan Cancer Hospital and Research Institute3
Chinese PLA General Hospital1
Fifth Affiliated Hospital, Sun Yat-Sen University1
Guangzhou Institute of Respiratory Disease1
Jiangsu HengRui Medicine Co., Ltd.1
RenJi Hospital1
Shanghai Gebaide Biotechnology Co., Ltd.1
The First Affiliated Hospital of Guangzhou Medical University1
The Second Hospital of Shandong University1
Wenzhou Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases14
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms4
Thoracic Neoplasms4
Bronchial Neoplasms3
Carcinoma, Bronchogenic3
Neoplasms3
Respiratory Tract Diseases3
Cardiovascular Diseases1
Hypertension, Pulmonary1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.